Found 328 clinical trials
Does your stomach pain and diarrhea come from Crohn's disease?
Does your stomach pain and diarrhea come from Crohn's disease?
- 110 views
- 08 Nov, 2020
- 1 location
A Phase 3 Clinical Trial for Patients with Moderately to Severely Active Crohn's Disease.
A Phase 3 Clinical Trial for Patients with Moderately to Severely Active Crohn's Disease.
- 274 views
- 08 Nov, 2020
- 1 location
The Scarlet Study for Adults with Moderately to Severely Active Crohn’s Disease
Before beginning the study, patients must go through a screening process to see if they meet the study eligibility requirements. The Screening Period will last about 5 weeks and includes tests and assessments performed at the study clinic.Patients who are eligible for this study will be randomly assigned (like the …
- 1 views
- 04 Jun, 2021
- 6 locations
A Washington University Crohn’s disease research study seeks participants.
The purpose of the study is to look at the effect of small bowel Crohn’s disease on lipoprotein after ingestion of a fatty meal in participants with and without Crohn’s disease. 
- 273 views
- 23 Nov, 2020
- 1 location
VIVID-1, a clinical research study for adults 18–80 with moderately to severely active Crohn’s disease.
A phase 3 research study of an injectable investigational medicine for adults ages 18 to 80 with moderate to severe Crohn’s disease. Note that study participants may receive the
- 79 views
- 13 Sep, 2021
- 77 locations
A Phase III, randomized, double-blind, placebo controlled, multicenter study to evaluate the efficacy and safety of Etrolizumab as an induction and maintenance treatment for patients with moderately to severe active Crohn's Disease.
to severe active Crohn's Disease.
- 180 views
- 25 Mar, 2021
- 1 location
A Phase 2a, Randomized, Doubleblind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients with Diarrhea predominant Irritable Bowel Syndrome (IBS-D)
no history of inflammatory or immune-mediated GI disorders including, but not limited to, inflammatory bowel disease (Crohn’s disease, ulcerative colitis, microscopic colitis, and celiac disease
- 73 views
- 20 Aug, 2019
- 1 location
Phase III, Double Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Etrolizumab During Induction and Maintenance in Patients With Moderate to Severe Active Ulcerative Colitis Who Are Refractory to or Intolerant of TNF Inhibitors
Phase III, Double Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Etrolizumab During Induction and Maintenance in Patients With Moderate to Severe Active Ulcerative Colitis Who Are Refractory to or Intolerant of TNF Inhibitors
- 182 views
- 25 Mar, 2021
- 1 location